Skip to main content

Table 1 Clinical characteristics of patients in training and validation sets

From: Identification of a TGF-β signaling-related gene signature for prediction of immunotherapy and targeted therapy for lung adenocarcinoma

Clinical features TCGA-LUAD GSE31210 GSE30219 GSE50081 GSE13213 GSE19188 GSE41271
OS
 0 318 191 40 76 68 16 112
 1 182 35 43 51 49 24 70
T stage
 T1 167   69 43    
 T2 267   12 82    
 T3 45   2 2    
 T4 18       
 TX 3       
N stage
 N0 324   80 94    
 N1 94   3 33    
 N2 69       
 N3 2       
 NX 11       
M stage
 M0 332   83 127    
 M1 24       
 MX 144       
Stage
 I 268 168   92 79   101
 II 119 58   35 13   28
 III 80     25   49
 IV 25       4
 X 8       
Gender
 Male 230 121 65   60 25 92
 Female 270 105 18   57 15 90
Age
  ≤ 65 237 176 60 40 78   
  > 65 253 50 23 87 39   
 NA 10       
Smoking
 1 71       
 2 119       
 3 129       
 4 163       
 5 4       
 7 14       
  1. Annotation: Lifelong non-smoker (less than 100 cigarettes smoked in lifetime) = 1; current smoker (includes daily smokers and non-daily smokers or occasional smokers) = 2; current reformed smoker for > 15 years (greater than 15 years) = 3; current reformed smoker for ≤ 15 years (less than or equal to 15 years) = 4; current reformed smoker, duration not specified = 5; smoking history not documented = 7